“With bipartisan legislation introduced to extend the X-Labs model to NIH, the scientific community should be asking whether the grass is truly greener on the institutional side, and what safeguards would prevent it from browning over time.”
www.science.org/doi/10.1126/...
Check out the latest study from CDUHR investigator Joy Scheidell-
Drug treatment and incident sexually transmitted infections among people who use drugs: a prospective analysis of gender differences
academic.oup.com/aje/advance-...
Amid chaos in US science and geopolitical turmoil, Europe wants to position itself as a research haven — but questions about funding and innovation remain 🧪
www.nature.com/articles/d41...
What would cuts to syringe service programs in the US do to #overdose?👇 @jama.com
The government is restricting funds for #harmreduction. This makes it difficult and/or impossible for organizations to do the work of keeping people alive, including syringe service programs. Strapped for funding, restricting and/or cutting more funding will make things worse. How do we know?
So here's the situation with @gilead.com
They hold the patent for a life-saving drug called Lenacapavir (LEN). 2 shots a year prevent you from getting HIV. It's a massive game changer for ending HIV transmission! But here's the catch:
Gilead won't sell it to Doctors Without Borders. 1/